PUBLISHER: GlobalData | PRODUCT CODE: 1535238
PUBLISHER: GlobalData | PRODUCT CODE: 1535238
ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a combined endoscopic and radiologic procedure for the ducts draining the liver and pancreas which includes bile ducts, gallbladder, and pancreatic ducts. Percutaneous Transhepatic Cholangiography (PTC) is useful in accessing the biliary tree when a high-grade stricture precludes endoscopic visualization or when prior surgery makes endoscopic access difficult.
ERCP and PTC devices are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These devices are also used for preventing pancreatitis and to drain the gallbladder and pancreatic fluids. These devices are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed ERCP and PTC Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, ConMed Corp, Cook Medical Inc, Olympus Corp, Merit Medical Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -